DrugDashboards

Market view

methylprednisolone acetate · Injection, Suspension

54 marketed package NDCs · 9 active manufacturers

Most dispensed: 80 mg/mL · Injection, Suspension · #1 vial, single-dose/carton / 1 ml in 1 vial, single-dose · 40 mg/mL · Injection, Suspension · #1 vial, multi-dose/carton / 10 ml in 1 vial, multi-dose · 80 mg/mL · Injection, Suspension · #1 vial, multi-dose/carton / 5 ml in 1 vial, multi-dose · 40 mg/mL · Injection, Suspension · #1 vial, single-dose/carton / 1 ml in 1 vial, single-dose

The short version

9 companies supply this market — a reasonable cushion if one runs into trouble. The generic price has fallen 30% in a year, to $5.81 per mL — and generics that get this cheap tend to get abandoned rather than defended. It is in shortage right now — FDA lists the reason as “demand increase for the drug.

Price range and competition

RSS: changes for this drug
priced separately — they are not the same market

Generic products only. Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.

$0$5.00$10.00$15.00Mar 2022Sep 2026011companies actively selling

Latest · Sep 2026 — typical price $5.81 · middle half $5.81$11.92 · full range $5.81$11.92 · 8 products · 11 companies

middle half of companies’ pricestypical (median) pricecompanies actively selling (bottom lane)Priced per mLSource: CMS NADAC
ⓘ How this was built
Data sources
  • CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
  • CMS Federal Upper Limit files (weighted AMP)
  • FDA NDC Directory (openFDA) — maker roster
Method

Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

What changed in the last 90 days

Every detected change for methylprednisolone acetate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Corticosteroid, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Methylprednisolone acetate in shortage right now?
Yes. FDA currently lists Methylprednisolone acetate in shortage, with the reason given as "demand increase for the drug". This page is rebuilt every morning from FDA's shortage database.
Who makes Methylprednisolone acetate?
23 companies have marketed Methylprednisolone acetate in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Methylprednisolone acetate cost?
The typical pharmacy pays about $6.88 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

Shortage reports for this molecule

  • In shortage nowMethylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01)Jun 16, 2022
  • In shortage nowDepo-medrol, Injection, 20 mg/1 mL (NDC 0009-0274-01)Dec 15, 2021
  • In shortage nowDepo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02)Dec 15, 2021
  • In shortage nowDepo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-03)Dec 15, 2021
  • In shortage nowDepo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-51)Dec 15, 2021
  • In shortage nowDepo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-52)Dec 15, 2021

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.